<!doctype html>
<html>

	<head>
		<meta charset="utf-8">
		<meta http-equiv="X-UA-Compatible" content="IE=edge">
		<meta name="viewport" content="width=device-width, initial-scale=1">
		<script type="text/javascript" src="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/js/jquery&action=raw&ctype=text/javascript"></script>
		<link type="text/css" rel="stylesheet" href="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/css/default&action=raw&ctype=text/css" />
		<script type="text/javascript" src="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/js/home&action=raw&ctype=text/javascript"></script>
		<link rel="stylesheet" href="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/css/bootstrap&action=raw&ctype=text/css">
		<script src="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/js/bootstrap&action=raw&ctype=text/javascript"></script>
		<link type="text/css" rel="stylesheet" href="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/css/style&action=raw&ctype=text/css" />
		<title>SYSU-Medicine</title>

		<script type="text/x-mathjax-config">
			$(function(){ MathJax.Hub.Config({ tex2jax: {inlineMath: [['$','$'], ['\\(','\\)']]} }); });
		</script>
		<script src="https://2019.igem.org/common/MathJax-2.5-latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
		<style>
			#model-content>div {
				/*for <h1> , figure, table */
				counter-reset: counter1 counter7 counter8;
			}
			
			#model-content {
				/*for fig*/
				/*counter-reset: counter7;*/
			}
			
			#model-head *,#model-content *{
				/* for table */
				/*counter-reset: counter8;*/
				font-family:"Times New Roman", Times, serif !important;
			}
			
			#model-head h1 {
				font-size: 48px;
			}
			
			#model-head h3 {
				font-size: 32px;
			}
			
			#model-content {
				counter-reset: counter7;
			}
			
			#model-content h1 {
				font-size: 48px !important;
				counter-reset: counter2;
				margin-top: 48px;
				margin-bottom: 48px;
			}
			
			#model-content h1:before {
				counter-increment: counter1;
				content: counter(counter1) ". ";
			}
			
			#model-content h2 {
				font-size: 40px !important;
				counter-reset: counter3;
				margin-top: 40px;
				margin-bottom: 40px;
			}
			
			#model-content h2:before {
				counter-increment: counter2;
				content: counter(counter1) "." counter(counter2) "  ";
			}
			
			#model-content h3 {
				font-size: 32px !important;
				counter-reset: counter4;
				margin-top: 32px;
				margin-bottom: 32px;
			}
			
			#model-content h3:before {
				counter-increment: counter3;
				content: counter(counter1) "." counter(counter2) "." counter(counter3) "  ";
			}
			
			#model-content h4 {
				font-size: 28px !important;
				counter-reset: counter5;
				margin-top: 28px;
				margin-bottom: 28px;
			}
			
			#model-content h4:before {
				counter-increment: counter4;
				content: counter(counter1) "." counter(counter2) "." counter(counter3) "." counter(counter4) "  ";
			}
			
			#model-content h5 {
				font-size: 24px !important;
				counter-reset: counter6;
				margin-top: 24px;
				margin-bottom: 24px;
			}
			
			#model-content h5:before {
				counter-increment: counter5;
				content: counter(counter1) "." counter(counter2) "." counter(counter3) "." counter(counter4) "." counter(counter5) "  ";
			}
			
			#model-content p {
				font-size: 18px !important;
				line-height: 180%;
				text-indent: 2em;
			}
			
			#model-content figure {
				text-align: center;
				margin-top: 48px;
				margin-bottom: 48px;
			}
			
			#model-content img {
				width:100%;
			}
			
			#model-content figure>figcaption:before {
				counter-increment: counter7;
				content: "Fig." counter(counter7) ": ";
			}
			
			#model-content caption {
				text-align: center;
				font-size: 18px;
				color: black;
			}
			
			#model-content caption:before {
				counter-increment: counter8;
				content: "Table " counter(counter8) ": ";
			}
		</style>
	</head>

	<body>
		<div class="container">
			<div class="row">
				<div class="col-sm-12 column">
					<nav class="navigation" id="nav-top">
						<ul class="navigation-list nav-justified">
							<div class="navigation-blue navigation-div">
								<li class="navigation-item activate ">
									<a class="navigation-item-link " href="https://2019.igem.org/Team:SYSU-Medicine">Home</a>
									<ul class="navigation-dropdown-panel"></ul>
								</li>
								<li class="navigation-item dropdown">
									<a class="navigation-item-link " href="https://2019.igem.org/Team:SYSU-Medicine/Description">Project</a>
									<ul class="navigation-dropdown-panel ">
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Description">Description</a>
										</li>
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Design">Design</a>
										</li>
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Results">Results</a>
										</li>
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Experiments">Experiments</a>
										</li>
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Inspiration">Inspiration</a>
										</li>
									</ul>
								</li>
								<li class="navigation-item dropdown">
									<a class="navigation-item-link" href="https://2019.igem.org/Team:SYSU-Medicine/Model">Model</a>
									<ul class="navigation-dropdown-panel">
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Model_Overview">Overview</a>
										</li>
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/M1_Cultivation">M1 Cultivation
											</a>
										</li>
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Injection_System">Injection System
											</a>
										</li>
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/TES">T. E. S.</a>
										</li>
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Future">Future</a>
										</li>
									</ul>
								</li>
								<li class="navigation-item dropdown ">
									<a class="navigation-item-link" href="https://2019.igem.org/Team:SYSU-Medicine/Human_Practices">Human Practices</a>
									<ul class="navigation-dropdown-panel ">
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Human_Practices_Overview">Overview
											</a>
										</li>
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Integrated_Practices">Integrated Practices
											</a>
										</li>
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Public_Engagement">Education & Engagement
											</a>
										</li>
									</ul>
								</li>

							</div>
							<div class="navigation-red navigation-div">
								<li class="navigation-item dropdown ">
									<a class="navigation-item-link " href="https://2019.igem.org/Team:SYSU-Medicine/Parts">Parts</a>
									<ul class="navigation-dropdown-panel ">
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Parts">Parts Overview</a>
										</li>
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Basic_Part">Basic Parts</a>
										</li>
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Composite_Part">Composite Parts
											</a>
										</li>
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Part_Collection">Part Collection
											</a>
										</li>
									</ul>
								</li>
								<li class="navigation-item dropdown ">
									<a class="navigation-item-link " href="https://2019.igem.org/Team:SYSU-Medicine/Team">Team</a>
									<ul class="navigation-dropdown-panel ">
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Team">Team Members</a>
										</li>
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Collaborations">Collaborations</a>
										</li>
										<li class="navigation-subitem">
											<a href="https://2019.igem.org/Team:SYSU-Medicine/Attributions">Attributions</a>
										</li>
									</ul>
								</li>
								<li class="navigation-item ">
									<a class="navigation-item-link" href="https://2019.igem.org/Team:SYSU-Medicine/Safety">Safety</a>
									<ul class="navigation-dropdown-panel"></ul>
								</li>
								<li class="navigation-item dropdown">
									<a class="navigation-item-link" href="https://2019.igem.org/Team:SYSU-Medicine/Medal">Awards</a>
									<ul class="navigation-dropdown-panel">
										<li class="navigation-subitem">
											<a href="https://igem.org/2019_Judging_Form?team=SYSU-Medicine">Judging</a>
										</li>
									</ul>
								</li>
							</div>

						</ul>
					</nav>
				</div>
			</div>
		</div>
		<br />
		<br />
		<br />
		<br />
		<br />
		<br />

		<div class="container">
			<div class="row clearfix">
				<div class="col-xs-8 col-xs-offset-2" id="model-head" style="text-align:center;">
					<h1 class="title">Modeling</h1>
				</div>
			</div>
			<div class="row clearfix" id="model-content">
				<div class="col-xs-12 col-md-8 col-md-offset-2 ">
					<h1 id="m1-cultivation">M1 Cultivation</h1>
					<h2 id="the-curve-of-titer-of-m1-with-time">The Curve of Titer of M1 with Time</h2>
					<p>In the process of the culture in vitro of oncolytic virus M1, there were uninfected vero cells, infected vero cells and oncolytic virus M1 in the medium. The change of the number of the microorganism is related to the number at the current moment of it. We used ordinary differential equation model to describe the change of the number of the three kinds of microorganisms with time.</p>
					<p>The relationship among the three kings of microorganism is shown in the figure below:</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/c/cb/T--SYSU-Medicine--ODE_00.png"  alt="" />
						<figcaption>
							The Transforming Relationship among the Three Kings of Microorganism
						</figcaption>
					</figure>
					<p>According to the mutual transformation relationship between the microorganism, the ordinary differential equations are established:</p>
					<p><br />
						<span class="math display">$$\left\{ \begin{aligned} \frac{dU(t)}{dt}&amp;=rU(t)(1-\frac{U(t)+I(t)}{K})-\beta U(t)M(t)\\ \frac{dI(t)}{dt}&amp;=\beta U(t)M(t)-\alpha I(t)\\ \frac{dM(t)}{dt}&amp;=\sigma I(t)-uM(t) \end{aligned} \right.$$</span><br /></p>
					<p>According to the experimental data and references, we obtained the values of parameters of M1 as follows <span class="math inline"><em></em><sup>[1]</sup></span>:</p>
					<p><br />
						<span class="math display"><em>r</em> = 0.95, <em>K</em> = 600, <em>β</em> = 0.27, <em>σ</em> = 1, <em>u</em> = 0.6</span><br /></p>
					<p>By using ode45 function in MATLAB to solve the system of ordinary differential equations, we obtained the number change curve of M1, infected vero cells and uninfected vero cells with time:</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/e/ea/T--SYSU-Medicine--ODE_Plot1.png"   alt="" />
						<figcaption>
							The Number Change curve of M1, Infected Vero Cells and Uninfected Vero Cells with Time<span label="figure 2"></span>
						</figcaption>
					</figure>
					<p>This is consistent with the growth rule of virus in vitro culture, which proves that our ordinary differential equations are reasonable.</p>
					<p>We use the solution to calculate the time-varying growth rate of M1, and find that 67.4701h is the time for the highest growth rate.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/e/ee/T--SYSU-Medicine--GrowthRate.png" alt="" />
						<figcaption>
							The Highest Growth Rate of M1
						</figcaption>
					</figure>
					<h2 id="m1-rna-point-mutation-model">M1 RNA Point Mutation Model</h2>
					<p>We first assumed that during the process, each site of the RNA mutates independently. That is, the mutation probability of each site is not affected by the mutation of other sites. At this time, the number of mutated sites of M1 obey Poisson Distribution within a certain time.</p>
					<p><br />
						<span class="math display">$$P(N(s,s+t]=k) = \frac{(\lambda t)^k}{k!}e^{-\lambda t}, k=0, 1, 2\cdots$$</span><br /></p>
					<p>The derivation with respect to t:<br />
						<span class="math display">$$\frac{\partial \frac{(\lambda t)^k}{k!}e^{-\lambda t}}{\partial t} = \frac{(\lambda)^k}{k!}e^{\lambda t}t^{k-1}(k-\lambda t) = 0$$</span><br /></p>
					<p>We have:</p>
					<p><br />
						<span class="math display">$$\hat{t} = \frac{k}{\lambda} = \frac{48k}{11000\alpha}$$</span><br /></p>
					<p>During the experiment, the mutation rate of the RNA of M1 is 0.01%, so we can get the curves describing the best time to collect M1 with specified number of mutation sites.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/3/3f/T--SYSU-Medicine--Possion.png" id="figure 3" alt="" />
						<figcaption>
							The Best Time to Collect M1 with k Mutation Sites<span label="figure 3"></span>
						</figcaption>
					</figure>
					<p>The best collection times are listed as below:</p>
					<table class="table table-bordered">
						<caption>
							The best collection times<span label="table 1"></span>
						</caption>
						<thead>
							<tr class="header">
								<th style="text-align: center;">k</th>
								<th style="text-align: center;">0</th>
								<th style="text-align: center;">1</th>
								<th style="text-align: center;">2</th>
								<th style="text-align: center;">3</th>
								<th style="text-align: center;">4</th>
							</tr>
						</thead>
						<tbody>
							<tr class="odd">
								<td style="text-align: center;">Best Time</td>
								<td style="text-align: center;">0h</td>
								<td style="text-align: center;">43.636h</td>
								<td style="text-align: center;">87.273h</td>
								<td style="text-align: center;">130.909h</td>
								<td style="text-align: center;">174.545h</td>
							</tr>
						</tbody>
					</table>
					<p>We can see that the probability of 2 point mutation is the highest at 87.273h. Combined with the best time for the growth rate of M1, the best interval to collect M1 who has a high growth rate and a high probability of 2 point mutation is<br />
						<span class="math display">[67.4701<em>h</em>, 87.273<em>h</em>].</span><br /> However, the growth rate curve seems to decent more sharply, so the best time is ought to get closer to 67.4701h. In a sense, 72h is a good option. Luckily, 72h is actually the best time for collection, confirmed by experiment. In a sense, our model is quite suitable for our experiment.</p>
					<p>Additionally, In order to make the model more scientific and reasonable, we consider that RNA sites of M1 may mutate interactively. Therefore, we adopt the Pearson Correlation Test to calculate the correlation of the RNA sites. <span class="math inline"><em></em><sup>[2]</sup></span> In fact, mutation rate 0.01% can be used under the assumption that the mutation is independent between sites. 0.01% is measured under experiment, which contains the situation that one site will be highly related to another site. Because in RNA, the relationship between sites is complex. If we consider the relationship of sites and estimate which site will mutate, the model will become very complex. In addition, the mutation data is hard to collect, and the relationship between sites is unknown. So there is significant for us to choose the Poisson Process, which can be accurate and effective.</p>
					<h1 id="injection-system">Injection System</h1>
					<p>In this section, our experiment focused on the medicine effect on the mouse. How can we measure the complex relationship between actinomycin D and M1? How does the concentration of nitroreductase grow with time? What is the best time and best prodrug volume for injection? Our models tried to solve these problems.</p>
					<p>The process of our treatment is complex. Because it contains the microcosmic process, in which M1, uninfected and infected tumor cells interact with each other. Besides it is related with macroscopic process, in which the prodrug quantity of injection has a complex relationship with the initial concentration of prodrug in partial area. So we separate the whole process into partial process and injection process, and then we analyze them detailedly.</p>
					<h2 id="partial-process">Partial Process</h2>
					<p>Tumor cells often gather in the specific area, that is why we choose the partial process for our research.</p>
					<p>In the partial process, the initial condition is the specific concentration of M1 and actinomycin D prodrug as the pro-medicine, along with the initial concentration of tumer cells. So we have the initial condition<br />
						<span class="math display"><em>U</em>(0) = <em>φ</em><sub><em>U</em></sub>, <em>I</em>(0) = 0, <em>M</em>(0) = <em>φ</em><sub><em>M</em></sub>, <em>c</em><sub><em>m</em></sub>(0) = <em>φ</em><sub><em>m</em></sub>, <em>c</em><sub><em>E</em></sub>(0) = 0</span><br /></p>
					<p>Then M1 will infect the tumor cells specifically. While in the tumor cells, M1 not only makes self replication but also translate the nitroreductase. The nitroreductase is so big that it can not be transported outsides. Luckily, our prodrug can enter the tumor cells due to its special perssad. So prodrug can be restored to actinomycin D under the help of nitroreductase. Actinomycin D producted could damage the tumor cells and at the same time, boost the production of nitroreductase.</p>
					<h3 id="tumor-and-m1">Tumor And M1</h3>
					<p>The process of tumor cells with M1 is similar to the process of veros with M1, so we obtain the ODE Model in the section 1. But we improve the model considering the effect of actinomycin D:<br />
						<span class="math display">$$\left\{ \begin{array}{lcl} \frac{dU(t)}{dt}=rU(t)(1-\frac{U(t)+I(t)}{K})-\beta U(t)M(t)-k_1 c_m(t)U(t)\\ \frac{dI(t)}{dt}=\beta U(t)M(t)-\alpha I(t)-k_2c_m(t)I(t)\\ \frac{dM(t)}{dt}=\sigma I(t)-uM(t)+\delta c_m(t) \end{array} \right.$$</span><br /></p>
					<p>In the improved ODE model, <span class="math inline"><em>k</em><sub>1</sub></span> is the coefficient of actinomycin D killing uninfected veros, while <span class="math inline"><em>k</em><sub>2</sub></span> is the coefficient of actinomycin D killing infected veros. In addition, let <span class="math inline"><em>δ</em></span> be the coefficient of actinomycin D boosting the growth of M1. The other coefficients are the same as in Section 1.</p>
					<h3 id="traditional-michaelis-menten-equation">Traditional Michaelis-Menten Equation</h3>
					<p>Now for the harder part. Our aim is to find out the influence of the changing concentration of the nitroreductase to the partial process. To find out the relationship of enzyme and reactant, we obtain the Michaelis-Menten Equation. In our experiment, the enzymatic reaction condition is suitable for the Michaelis-Menten Equation, especially for the assumption of Briggs-Haldane improved model.</p>
					<p><br />
						<span class="math display"><em>E</em> + <em>S</em> ↔︎ <em>E</em><em>S</em> → <em>E</em> + <em>P</em></span><br /> So there is convincing to use the Michaelis-Menten Model.</p>
					<p>Let <span class="math inline"><em>c</em><sub><em>p</em></sub></span> be the concentration of prodrug, while <span class="math inline"><em>c</em><sub><em>m</em></sub></span> is the concentration of actinomycin D. <span class="math inline"><em>c</em><sub><em>p</em></sub></span> and <span class="math inline"><em>c</em><sub><em>m</em></sub></span> are the total concentration <span class="math inline"><em>c</em><sub><em>t</em><em>o</em><em>t</em><em>a</em><em>l</em></sub></span>,<br />
						<span class="math display"><em>c</em><sub><em>t</em><em>o</em><em>t</em><em>a</em><em>l</em></sub> = <em>c</em><sub><em>m</em></sub> + <em>c</em><sub><em>p</em></sub></span><br /> for the ratio of reactant and product in our chemical equation is one to one. First we assume that the concentration of nitroreductase is constant, so the model is<br />
						<span class="math display">$$\frac{dc_p}{dt}=-\frac{dc_m}{dt}=-\frac{\beta_1 c_p}{\beta_2+c_p}$$</span><br /> .
					</p>
					<p>The integral of the equation is below (we have considered the initial condition of our model).<br />
						<span class="math display">$$\left\{ \begin{array}{lcl} c^{\beta_2}_p e^{c_p}=e^{-\beta_1(t+c^*)}\\ (c_{total}-c_m)^{\beta_2}e^{c_{total}-c_m}=e^{-\beta_1 (t+c^*)}\\ c^*=-\frac{\beta_2 ln c_{total}+c_{total}}{\beta_1} \end{array} \right .$$</span><br /> then we get the figure of traditional Michaelis-Menten Equation that</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/1/11/T--SYSU-Medicine--S2P1.png" alt="" />
						<figcaption>
							The Concentration of Prodrug And the Rate of Actinomycin D Production
						</figcaption>
					</figure>
					<h3 id="improved-michaelis-menten-equation">Improved Michaelis-Menten Equation</h3>
					<p>However, the concentration of nitroreductase is time-varying because it can be produced by the M1-infected tumor cells. Based on the usual method of Michaelis-Menten Equation and for the convenience as well, we assume that the coefficients of Traditional Michaelis-Menten Equation <span class="math inline"><em>β</em><sub>1</sub></span> and <span class="math inline"><em>β</em><sub>2</sub></span> are the affine transformation of the concentration of nitroreductase <span class="math inline"><em>c</em><sub><em>E</em></sub></span>. So the differential form of our improved Michaelis-Menten Equation is<br />
						<span class="math display">$$\frac{dc_p}{dt}=-\frac{dc_m}{dt}=-\frac{(\beta_1+\gamma_1 c_E) c_p}{(\beta_2+\gamma_2 c_E)+c_p} .$$</span><br /></p>
					<p>Then we obtain the integral form of the improved Michaelis-Menten Equation as</p>
					<p><br />
						<span class="math display">$$\left\{ \begin{array}{lcl} c^{\beta_2+\gamma_2 c_E}_p e^{c_p}=e^{-(\beta_1+\gamma_1 c_E)(t+c^*)}\\ (c_{total}-c_m)^{\beta_2+\gamma_2 c_E}e^{c_{total}-c_m}=e^{(-\beta_1+\gamma_1 c_E) (t+c^*)}\\ c^*=-\frac{(\beta_2+\gamma_2 c_E) ln c_{total}+c_{total}}{\beta_1+\gamma_1 c_E} \end{array} \right .$$</span><br /></p>
					<p>The figure of the equation is below.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/5/5c/T--SYSU-Medicine--IMME1.png" alt="" />
						<figcaption>
							The Concentration of Nitroreductase, Time and Concentration of Actinomycin D
						</figcaption>
					</figure>
					<h3 id="integrated-partial-process-ode-model">Integrated Partial Process ODE Model</h3>
					<p>Now, we have to consider the influence of the time-varying concentration of nitroreductase to the process.</p>
					<p>We know that the concentration of nitroreductase can rise up just due to the M1 infection. And it will decrease because of the death of infected tumor cells. These are two main ways to influence the concentration of nitroreductase.</p>
					<p>Finally, we get the ODE model of partial process as follows.</p>
					<p><br />
						<span class="math display">$$\left\{ \begin{array}{lcl} \frac{dU(t)}{dt}=rU(t)(1-\frac{U(t)+I(t)}{K})-\beta U(t)M(t)-k_1 c_m(t)U(t)\\ \frac{dI(t)}{dt}=\beta U(t)M(t)-\alpha I(t)-k_2c_m(t)I(t)\\ \frac{dM(t)}{dt}=\sigma I(t)-uM(t)+\delta c_m(t)\\ \frac{dc_m}{dt}=\frac{(\beta_1+\gamma_1 c_E) (c_{total}-c_m)}{(\beta_2+\gamma_2 c_E)+ (c_{total}-c_m)}\\ \frac{dc_E(t)}{dt}=k_3M(t)-k_4(\alpha I(t)+k_2 c_m(t)I(t)) \end{array} \right .$$</span><br /></p>
					<p>In our equation group, the first equation ends with the element containing <span class="math inline"><em>U</em>(<em>t</em>)</span> to avoid the situation that the rate is under zero. It is the same in the second equation. The initial condition of our equation group is<br />
						<span class="math display"><em>U</em>(0) = <em>φ</em><sub><em>U</em></sub>, <em>I</em>(0) = 0, <em>M</em>(0) = <em>φ</em><sub><em>M</em></sub>, <em>c</em><sub><em>m</em></sub>(0) = <em>φ</em><sub><em>m</em></sub>, <em>c</em><sub><em>E</em></sub>(0) = 0.</span><br /></p>
					<p>Thus, we obtain the ode45 or ode15s to solve the equation group numerically.</p>
					<h3 id="parameter-estimation">Parameter Estimation</h3>
					<p>The number of our equation group is big in some way. Some of the parameters can be estimated by other methods (such as measurement), but some of them can only be estimated by fitting the data.</p>
					<p>In the Improved Michaelis-Menten Equation, <span class="math inline"><em>β</em><sub>1</sub></span> and <span class="math inline"><em>β</em><sub>2</sub></span> are related with the concentration of nitroreductase linearly. So we use the linear regression model to fit the data. We should first measure the 5 min rate under different concentration of nitroreductase and then fit the data with traditional model in section 2.1.2, in order to get the estimated parameters <span class="math inline"><em>β</em><sub>1</sub></span> and <span class="math inline"><em>β</em><sub>2</sub></span> that exist in the traditional Michaelis-Menten Equation. Next we use linear regression model to find out the relationship between <span class="math inline"><em>c</em><sub><em>E</em></sub></span> and <span class="math inline"><em>β</em><sub>1</sub></span>, <span class="math inline"><em>β</em><sub>2</sub></span>. Besides our method, there are Lineweaver-Buck Method and Wilkinson Method. However, the error in our method is the lowest among three.</p>
					<p>In our experiment, the prodrug production is low. We haven’t measured the concentration of drug under different concentration of nitroreductase. However, we will finish the parameters estimation of our model based on the method we used above. We analyse the model based on different paramter values. We first analyse the effect of <span class="math inline"><em>β</em><sub>1</sub></span>, and find that it only affects the maximum of the curve. <span class="math inline"><em>β</em><sub>2</sub></span> affects the rate of getting to the maximum.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/0/05/T--SYSU-Medicine--team-Model-MME_Parameter.png"  alt="" />
						<figcaption>
							Parameter Estimation of Michaelis-Menten Equation
						</figcaption>
					</figure>
					<h2 id="injection-process">Injection Process</h2>
					<p>In this section, we will take the process of prodrug from injection to targeting area into consideration. In addition, we only consider the situation in immune-free mouse in the one-injection curve.</p>
					<h3 id="indicator">Indicator</h3>
					<p>To measure the degree of pesticide effect, kill rate is an indicator that is often used in the medicine research. In our research, instantaneous kill rate is more important, for it can change greatly, catching our attention. So we all consider instantaneous kill rate as our index. We assume that kill rate is related with the concentration of M1 and actinomycin D. Theoretically, M1 and actinomycin D kill tumor cells independently. However, they influence each other actually. So we have to add the method of Elastic Net or interation term to eliminate the autocorrelation of them (we choose the latter one). Furthermore, kill rate has positive correlation with the concentration of tumor cells (in our model we use ratio of survived tumor cells), so we finally show that</p>
					<p><br />
						<span class="math display"><em>R̂</em><sub><em>k</em><em>i</em><em>l</em><em>l</em></sub> = (<em>β</em><sub>1</sub><em>c</em><sub><em>a</em><em>c</em><em>t</em><em>i</em><em>n</em></sub> + <em>β</em><sub>2</sub><em>c</em><sub><em>M</em>1</sub> + <em>β</em><sub>3</sub><em>c</em><sub><em>a</em><em>c</em><em>t</em><em>i</em><em>n</em></sub><em>c</em><sub><em>M</em>1</sub> + <em>β</em><sub>4</sub>)<em>R</em><sub><em>t</em><em>u</em><em>m</em><em>o</em><em>r</em></sub><sup><em>α</em></sup>, 0 &lt; <em>α</em> &lt; 1</span><br /></p>
					<p>To guarantee value of kill rate in <span class="math inline">[0, 1]</span>, we use the function <span class="math inline"><em>ϕ</em>(<em>x</em>) = 1 − <em>e</em><sup> − <em>x</em></sup></span>. In our experiment, the parameters are estimated by the data in confirming the validity of actinomycin D boosting the therapy of M1. The parameters are <span class="math inline"><em>β</em><sub>1</sub> = 0.6615</span>, <span class="math inline"><em>β</em><sub>2</sub> = 0.3418</span>, <span class="math inline"><em>β</em><sub>3</sub> = 1.9844</span>, <span class="math inline"><em>β</em><sub>4</sub> = 0</span> and <span class="math inline"><em>α</em> = 1</span>. Then we get the kill rate function and the figure.</p>
					<p><br />
						<span class="math display"><em>R</em><sub><em>k</em><em>i</em><em>l</em><em>l</em></sub> = 1 − <em>e</em><sup> − (0.6615<em>c</em><sub><em>a</em><em>c</em><em>t</em><em>i</em><em>n</em><em>o</em><em>m</em><em>y</em><em>c</em><em>i</em><em>n</em> <em>D</em></sub> + 0.3418<em>c</em><sub><em>M</em>1</sub> + 1.9844<em>c</em><sub><em>a</em><em>c</em><em>t</em><em>i</em><em>n</em><em>o</em><em>m</em><em>y</em><em>c</em><em>i</em><em>n</em><em>D</em></sub><em>c</em><sub><em>M</em>1</sub>)<em>R</em><sub><em>c</em><em>a</em><em>n</em><em>c</em><em>e</em><em>r</em></sub></sup></span><br /></p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/7/77/T--SYSU-Medicine--KillRate.png" alt="" />
						<figcaption>
							The Kill Rate Function
						</figcaption>
					</figure>
					<h3 id="compartment-model">Compartment Model</h3>
					<p>To estimate the time-varying distribution of prodrug, we obtain the compartment model. A very important assumption in our compartment model is that medicine follows the uniform distribution in a room.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/4/41/T--SYSU-Medicine--P1.png" alt="" />
						<figcaption>
							The Concentration of Prodrug And the Rate of Actinomycin D Prodution
						</figcaption>
					</figure>
					<p>Thus we also use the ODE model according to the relationship in the process.</p>
					<p><br />
						<span class="math display">$$\left\{ \begin{array}{lcl} \dot{x}_1(t)=-k_{12}x_1-k_{13}x_1+k_{21}x_2+f_0(t)\\ \dot{x}_2(t)=k_{12}x_1-k_{21}x_2 \end{array} \right.$$</span><br /></p>
					<p>We know that the concentration <span class="math inline"><em>c</em>(<em>t</em>)</span> multipling the volume <span class="math inline"><em>V</em></span> is the quantity <span class="math inline"><em>x</em>(<em>t</em>)</span>.<br />
						<span class="math display"><em>x</em><sub><em>i</em></sub>(<em>t</em>) = <em>V</em><sub><em>i</em></sub><em>c</em><sub><em>i</em></sub>(<em>t</em>), <em>i</em> = 1, 2</span><br /></p>
					<p>And then we can get that<br />
						<span class="math display">$$\left \{ \begin{array}{lcl} \dot{c}_1(t)=-(k_{12}+k_{13})c_1+\frac{V_2}{V_1}k_{21}c_2+\frac{f_0(t)}{V_1}\\ \dot{c}_2(t)=\frac{V_1}{V_2}k_{12}c_1-k_{21}c_2 \end{array} \right.$$</span><br /></p>
					<p>In our experiment, the type of injection is rapid intravenous injection. So <span class="math inline"><em>f</em><sub>0</sub>(<em>t</em>)</span> and the initial condition is</p>
					<p><br />
						<span class="math display">$$\left \{ \begin{array}{lcl} f_0(t)=0\\ c_1(0)=\frac{D_0}{V_1}\\ c_2(0)=0 \end{array} \right .$$</span><br /></p>
					<p>Then we could get the solution of our equation that<br />
						<span class="math display">$$\left \{ \begin{array}{lcl} c_1(t)=Ae^{-\alpha t}+Be^{-\beta t}\\ c_2(t)=\frac{D_0 k_12}{V_2 (\beta-\alpha)}(e^{-\alpha t}-e^{\beta}) \end{array} \right .$$</span><br /></p>
					<p>The parameters in the model are<br />
						<span class="math display">$$\left \{ \begin{array}{lcl} A=\frac{D_0(k_{21}-\alpha)}{V_1(\beta-\alpha)}\\ B=\frac{D_0(\beta-k_{21})}{V_1(\beta-\alpha)}\\ \alpha+\beta=k_{12}+k_{21}+k_{13}\\ \alpha \beta=k_{21}k_{13} \end{array} \right .$$</span><br /></p>
					<p>Then we can get the time-varying concentration of total medicine.</p>
					<h3 id="parameter-estimation-1">Parameter Estimation</h3>
					<p>In our experiment, the concentration of actinomycin D is measured under different time. We can see the data in the table.</p>
					<table class="table table-bordered">
						<caption>
							Prodrug Concentration in Blood System
						</caption>
						<thead>
							<tr class="header">
								<th style="text-align: left;"><span class="math inline"><em>t</em><sub><em>i</em></sub></span></th>
								<th style="text-align: left;">1</th>
								<th style="text-align: left;">2</th>
								<th style="text-align: left;">4</th>
								<th style="text-align: left;">8</th>
								<th style="text-align: left;">16</th>
								<th style="text-align: left;">24</th>
								<th style="text-align: left;">36</th>
							</tr>
						</thead>
						<tbody>
							<tr class="odd">
								<td style="text-align: left;"><span class="math inline"><em>c</em>(<em>t</em><sub><em>i</em></sub>)<em>μ</em><em>g</em>/<em>m</em><em>L</em></span></td>
								<td style="text-align: left;">0.1005</td>
								<td style="text-align: left;">0.0845</td>
								<td style="text-align: left;">0.0638</td>
								<td style="text-align: left;">0.0349</td>
								<td style="text-align: left;">0.0136</td>
								<td style="text-align: left;">0.0044</td>
								<td style="text-align: left;">0.0020</td>
							</tr>
						</tbody>
					</table>
					<p>Then we use the former 4 iterations and latter 4 iterations to suit the model <span class="math inline">ln <em>c</em>(<em>t</em>) = ln <em>P</em><sub>1</sub> − <em>P</em><sub>2</sub><em>t</em></span> and we finally get that <span class="math inline"><em>A</em> = 0.09154</span>, <span class="math inline"><em>α</em> = 0.1204</span>, <span class="math inline"><em>B</em>=</span> and <span class="math inline"><em>β</em> =  − 0.009719</span>. And we calculate other parameters that are shown in the coming table.</p>
					<table class="table table-bordered">
						<caption>
							Parameter Estimation
						</caption>
						<thead>
							<tr class="header">
								<th style="text-align: left;">A</th>
								<th style="text-align: left;">0.09154</th>
								<th style="text-align: left;"><span class="math inline"><em>k</em><sub>21</sub></span></th>
								<th style="text-align: left;">0.1337</th>
							</tr>
						</thead>
						<tbody>
							<tr class="odd">
								<td style="text-align: left;"><span class="math inline"><em>α</em></span></td>
								<td style="text-align: left;">0.1204</td>
								<td style="text-align: left;"><span class="math inline"><em>k</em><sub>13</sub></span></td>
								<td style="text-align: left;">0.1356</td>
							</tr>
							<tr class="even">
								<td style="text-align: left;">B</td>
								<td style="text-align: left;">0.1159</td>
								<td style="text-align: left;"><span class="math inline"><em>k</em><sub>12</sub></span></td>
								<td style="text-align: left;">0.0017</td>
							</tr>
							<tr class="odd">
								<td style="text-align: left;"><span class="math inline"><em>β</em></span></td>
								<td style="text-align: left;">0.1506</td>
								<td style="text-align: left;"></td>
								<td style="text-align: left;"></td>
							</tr>
						</tbody>
					</table>
					<p>The figure that contains the nonlinear fitting method is below.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/4/4e/T--SYSU-Medicine--team-Model-PE1.png" alt="" />
						<figcaption>
							The Concentration of Prodrug And Nonlinear Fitting
						</figcaption>
					</figure>
					<p>Then we could see that the concentration of mixed prodrug changes as time goes by. If we only inject the mouse once, the time-varying concentration of mixed prodrug and Half-Life Period are provided in the figure. We also provide the concentration of M1 both in the serum and tumor area. Compared with the data, our model curve is suitable for our research.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/f/ff/T--SYSU-Medicine--team-Model-hl111.png" alt="" />
						<figcaption>
							The Actual Data and the Concentration of Mixed Prodrug in Blood System and Tumor Area
						</figcaption>
					</figure>
					<h2 id="integrated-injection-model">Integrated Injection Model</h2>
					<p>Now we have the Partial Process and Injection Process, and then we want to mix them into one process. The concentration of total medicine in the tumor area is only related to the Compartment Model, and limits the time-varying partial process. Thus we could get the curve of concentration of tumor cells, titer of M1, concentration of nitroreductase, and concentration of actinomycin D in blood system and in tumor area as follows.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/b/b9/T--SYSU-Medicine--team-Model-CI.png" alt="" />
						<figcaption>
							Integrated Injection Model with One Injection
						</figcaption>
					</figure>
					<p>As for the instantaneous kill rate, we first analyse the data we got. Here is the relationship matrix of the concentration of uninfected tumor cells, infected tumor cells, titer of M1 and the concentration of actinomycin D. The data is from our model. Searching for the relationship between two variable just based on our model can not be convincing. However, there is rule between them which can be confirmed not just from references but from our experiment. Thus, we consider the possible error in our model by adding Gaussian noise.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/1/1a/T--SYSU-Medicine--team-Model-Relationship_Matrix.png"  alt="" />
						<figcaption>
							Relationship Analysis
						</figcaption>
					</figure>
					<p>We can see that there are strong relationship between variables. The relationship above confirm our assumption. Thus, the index Instantaneous Kill Rate is reasonable. And we get the time-varying Instantaneous Kill Rate as follow.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/b/b9/T--SYSU-Medicine--team-Model-Decision_Instantaneous_Kill_Rate.png"  alt="" />
						<figcaption>
							Instantaneous Kill Rate
						</figcaption>
					</figure>
					<p>Finally, we could get the injection regime by adapting the curve to the upper and lower boundary. After trying a lot of times, we find that <span class="math inline">0.58<em>μ</em><em>g</em>/<em>m</em><em>L</em></span> is the best injection quantity in the experiment. (The value of best injection time is a little different in this figure compared to the above figure, because we use the Runge Kutta Algorithm to solve the impulsive differential equation, which can be less complex than the exact solution in coding.)</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/a/ab/T--SYSU-Medicine--team-Model-injectionRegime.png" alt="" />
						<figcaption>
							Integrated Injection Model with One Injection
						</figcaption>
					</figure>
					<h2 id="video-of-2-dimentional-distribution">Video of 2-dimentional Distribution</h2>
					<p>To see the time-varying distribution of M1 inside mouse, we select 6 photos of 2 mice with fluorescent and a photo of these 2 mice without fluorescent. We convert every image into an RGB matrix. Then we try to transform the 6 matrixs and reduce the target dimension. Next we try to use BP neural network to fit the time-varying image and create 121 photos. Finally we make these images into movie.</p>
					<div class="row clearfix">
						<div class="col text-center">
							<video controls="controls center-block">
								<source src="https://2019.igem.org/wiki/images/1/1c/T--SYSU-Medicine--model_video.mp4" type="video/mp4">
							</video>
							<p>Video of 2-dimentional Distribution</p>
						</div>
					</div>
					<h1 id="targeting-ability-effectiveness-and-safety">Targeting Ability, Effectiveness and Safety</h1>
					<h2 id="targeting-ability">Targeting Ability</h2>
					<p>To evaluate the in vivo antitumor potential of M1, we established a preclinical tumor models. We selected several groups of male and female mice and gave them a rapid intravenous injection of M1.The concentration of M1 was collected in different parts of the mouse body, and the mean value was taken to plot the results, as shown in the figure below.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/e/e7/T--SYSU-Medicine--team-Model-12.png" alt="" />
						<figcaption>
							The concentration of M1 was collected in different parts of the male mouse body
						</figcaption>
					</figure>
					<figure>
						<img src="https://2019.igem.org/wiki/images/f/ff/T--SYSU-Medicine--team-Model-13.png" alt="" />
						<figcaption>
							The concentration of M1 was collected in different parts of the female mouse body
						</figcaption>
					</figure>
					<p>From the experimental results, we can see that M1 is enriched in the tumor area in mice.In other parts of the mice, the concentration level of M1 was low, which was close to the level of normal mice, which reflected the targeted effect of M1 and thus ensured the targeted effect of combined therapy.</p>
					<h2 id="effectiveness">Effectiveness</h2>
					<h3 id="fitness">Fitness</h3>
					<p>Meanwhile, the mean value of Tumor Volumn in both control and experimental mice was obtained, as shown in the table below.<span class="math inline"><em></em><sup>[1]</sup></span></p>
					<table class="table table-bordered">
						<caption>
							Tumor Volumn in both control and experimental mice<span label="table"></span>
						</caption>
						<thead>
							<tr class="header">
								<th style="text-align: center;"></th>
								<th style="text-align: center;">3</th>
								<th style="text-align: center;">6</th>
								<th style="text-align: center;">9</th>
								<th style="text-align: center;">12</th>
								<th style="text-align: center;">15</th>
								<th style="text-align: center;">18</th>
								<th style="text-align: center;">21</th>
							</tr>
						</thead>
						<tbody>
							<tr class="odd">
								<td style="text-align: center;">M1</td>
								<td style="text-align: center;">0.12</td>
								<td style="text-align: center;">0.20</td>
								<td style="text-align: center;">0.28</td>
								<td style="text-align: center;">0.40</td>
								<td style="text-align: center;">0.68</td>
								<td style="text-align: center;">0.88</td>
								<td style="text-align: center;">0.95</td>
							</tr>
							<tr class="even">
								<td style="text-align: center;">Control</td>
								<td style="text-align: center;">0.10</td>
								<td style="text-align: center;">0.11</td>
								<td style="text-align: center;">0.14</td>
								<td style="text-align: center;">0.15</td>
								<td style="text-align: center;">0.18</td>
								<td style="text-align: center;">0.28</td>
								<td style="text-align: center;">0.42</td>
							</tr>
						</tbody>
					</table>
					<p>We used Fourier and Gaussian functions to fit the images of M1 and the control group, the table is as below:</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/e/ef/T--SYSU-Medicine--team-Model-15.png" alt="" />
						<figcaption>
							Tumor Volumn in both control and experWe know this from experiments on ten primate cynomolgus monkeysimental mice
						</figcaption>
					</figure>
					<p>Consistent with the in vitro experiments, evident antitumor effects were observed in M1-treated animals.</p>
					<h3 id="improved-ode-model">Improved ODE Model</h3>
					<p>Considering the different environment in human body because of the immune effect and the limitation of the number of uninfected tumour cells <span class="math inline"><em>U</em>(<em>t</em>)</span>, infected tumour cells <span class="math inline"><em>I</em>(<em>t</em>)</span>, we decided to change our model:<span class="math inline"><em></em><sup>[2]</sup></span><br />
						<span class="math display">$$\left\{ \begin{aligned} \frac{dU(t)}{dt}&amp;=r*U(t)*\frac{1}{\varphi*U(t)+\psi*I(t)}-\beta U(t)M(t)\\ \frac{dI(t)}{dt}&amp;=r*I(t)*\frac{1}{\varphi*U(t)+\psi*I(t)}+\beta U(t)M(t)-\alpha I(t)-\frac{I(t)}{I(t)+U(t)}\\ \frac{dM(t)}{dt}&amp;=\sigma I(t)-uM(t)-M(t)*\frac{I(t)}{I(t)+U(t)}\\ \end{aligned} \right.$$</span><br /> In the equations above, <span class="math inline"><em>M</em>(<em>t</em>)</span>is the titer of the M1. The proportion of infected tumour cells among all the tumor cells as <span class="math inline">$\frac{I(t)}{I(t)+U(t)}$</span> means the immune effect on the titer of the infected tumour, meanwhile, in order to take the limitation of tumour cells to themselves into consideration, we add <span class="math inline">$\frac{1}{\varphi*U(t)+\psi*I(t)}$</span> to show the counteraction to its own growth with a large amount of tumour.</p>
					<p>The solution of the equations is showed below:</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/9/92/T--SYSU-Medicine--team-Model-ImprovedODE.png" alt="" />
						<figcaption>
							text
						</figcaption>
					</figure>
					<p>This solution is more reasonable. It proves the effectiveness of M1 with the reduction of the uninfected tumour cells. Obviously the solution tends to be stable and the infected tumour cells will gradually become zero. In addition, the remain of the tumour cells also prove that the second dose is necessary.</p>
					<h2 id="safety">Safety</h2>
					<p>As for the safety of our system, we know this from experiments on ten primate cynomolgus monkeys. In this experiment, Ten captive-bred 4 to 6-year-old male- or female- specific pathogen-free cynomolgus macaques (M. fascicularis) weighing between 3.5 and 6 kg were obtained and Five randomly selected macaques were treated with oncolytic virus M1; the left five ones were subjected to the control group–receiving vehicle after the same schedule as the virus injections in the test group. All animals were bled 2 days before viral injection to confirm the absence of neutralizing antibodies.<span class="math inline"><em></em><sup>[3]</sup></span></p>
					<p>During the experiment, the body weight and body temperature of experimental macaques and control macaques were measured weekly. In addtional, the count of white blood cells, lymphocyte,monocyte, albumin(ALB), globulin(GLB), aspartate amino-transferase (AST) , alanine transaminase (ALT), alkaline phosphatase (ALP) Were examined and counted. The results are listed as below:</p>
					<table class="table table-bordered">
						<caption>
							Tumor Volumn in both control and experimental mice<span label="table"></span>
						</caption>
						<thead>
							<tr class="header">
								<th style="text-align: center;">Diagnosis</th>
								<th style="text-align: center;">Control</th>
								<th style="text-align: center;">Test</th>
								<th style="text-align: center;">p value</th>
							</tr>
						</thead>
						<tbody>
							<tr class="odd">
								<td style="text-align: center;">Body weight</td>
								<td style="text-align: center;">5.26 <span class="math inline">±</span> 1.39</td>
								<td style="text-align: center;">5.81 <span class="math inline">±</span> 0.8</td>
								<td style="text-align: center;">0.2099752 <span class="math inline">≥</span> 0.05</td>
								
							</tr>
							<tr class="even">
								<td style="text-align: center;">Body temperature</td>
								<td style="text-align: center;">38.42 <span class="math inline">±</span> 0.48</td>
								<td style="text-align: center;">38.22 <span class="math inline">±</span> 0.52</td>
								<td style="text-align: center;">0.2536536 <span class="math inline">≥</span> 0.05</td>
							</tr>
							<tr class="odd">
								<td style="text-align: center;">WBC,cells/nl</td>
								<td style="text-align: center;">11.12 <span class="math inline">±</span> 4.31</td>
								<td style="text-align: center;">9.54 <span class="math inline">±</span> 4.01</td>
								<td style="text-align: center;">0.2640504 <span class="math inline">≥</span> 0.05</td>
							</tr>
							<tr class="even">
								<td style="text-align: center;">LY,%</td>
								<td style="text-align: center;">34.72 <span class="math inline">±</span> 9.62</td>
								<td style="text-align: center;">51.16 <span class="math inline">±</span> 12.14</td>
								<td style="text-align: center;">0.006704666</td>
							</tr>
							<tr class="odd">
								<td style="text-align: center;">MONO,%</td>
								<td style="text-align: center;">4.86 <span class="math inline">±</span> 2.32</td>
								<td style="text-align: center;">5.2 <span class="math inline">±</span> 3.17</td>
								<td style="text-align: center;">0.3722814 <span class="math inline">≥</span> 0.05</td>
							</tr>
							<tr class="even">
								<td style="text-align: center;">AST,U/liter</td>
								<td style="text-align: center;">28 <span class="math inline">±</span> 5.24</td>
								<td style="text-align: center;">28.2 <span class="math inline">±</span> 4.55</td>
								<td style="text-align: center;">0.3862507 <span class="math inline">≥</span> 0.05</td>
							</tr>
							<tr class="odd">
								<td style="text-align: center;">ALT,U/liter</td>
								<td style="text-align: center;">32.4 <span class="math inline">±</span> 16.77</td>
								<td style="text-align: center;">26.4 <span class="math inline">±</span> 3.78</td>
								<td style="text-align: center;">0.2056938 <span class="math inline">≥</span> 0.05</td>
							</tr>
							<tr class="even">
								<td style="text-align: center;">ALB,g/liter</td>
								<td style="text-align: center;">44.66 <span class="math inline">±</span> 2.79</td>
								<td style="text-align: center;">46.22 <span class="math inline">±</span> 1.81</td>
								<td style="text-align: center;">0.1300045 <span class="math inline">≥</span> 0.05</td>
							</tr>
							<tr class="odd">
								<td style="text-align: center;">GLB,g/liter</td>
								<td style="text-align: center;">32 <span class="math inline">±</span> 3.50</td>
								<td style="text-align: center;">30.26 <span class="math inline">±</span> 4.11</td>
								<td style="text-align: center;">0.2247176 <span class="math inline">≥</span> 0.05</td>
							</tr>
							<tr class="even">
								<td style="text-align: center;">ALP,U/liter</td>
								<td style="text-align: center;">175 <span class="math inline">±</span> 76</td>
								<td style="text-align: center;">181.8 <span class="math inline">±</span> 70.48</td>
								<td style="text-align: center;">0.3788848 <span class="math inline">≥</span> 0.05</td>
							</tr>
						</tbody>
					</table>
					<p>We run hypothesis tests on the data:</p>
					<p><span class="math inline"><em>H</em><sub>0</sub></span>: No statistically significant differences</p>
					<p><span class="math inline"><em>H</em><sub>1</sub></span>: There are statistically significant differences</p>
					<p>All the examinations mentioned above were performed to evaluate the potential comprehensive long-term effects of multiple rounds of injections on macaques. As shown in Table, no significant differences can be found in the test group compared withthe control, except for the increased percentage of lymphocytes in the white blood cells, which is a common phenomenon during virus infection.</p>
					<p>That is to say we should accept the <span class="math inline"><em>H</em><sub>0</sub></span>, and our system is safe and dependable in a way.</p>
					<p>The details of this experiment can be seen in the reference.</p>
					<h2 id="the-contact-ratio-beta-and-spatial-distribution">*The Contact Ratio <span class="math inline"><em>β</em></span> and Spatial Distribution</h2>
					<p>Actually, in the research, the contact ratio <span class="math inline"><em>β</em></span> is different due to the position. The uninfected tumor cells tend to have a higher contact ratio when they are around an infected tumor cell. And as we can see, <span class="math inline"><em>β</em></span> decreases as the cells move away from the infected one. Thus, we should consider the distribution of infected tumor cells.</p>
					<p>We could collect the fluorescent figure of different time, and regard the fluorescent points as points in the plot. Then we could use k-means to cluster. And we can get the mean and variance of each cluster. Thus we can use Gaussian Mixture Model to make an approximate distribution based on the clustering. That is because the gaussian mixture distribution can approximate the non - negative integrable function with arbitrary precision. Then we could get the figure below.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/4/4b/T--SYSU-Medicine--team-Model-GMM.png" alt="" />
						<figcaption>
							Clustering and Gaussian Mixture Model
						</figcaption>
					</figure>
					<p>Basee on the GMM, we could finally get the distribution of infected tumor cells. It is the distribution of the contact ratio <span class="math inline"><em>β</em></span> as well.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/0/09/T--SYSU-Medicine--team-Model-beta.png"  alt="" />
						<figcaption>
							<span class="math inline"><em>β</em></span> Distribution
						</figcaption>
					</figure>
					<p>The similar method can be applied into 3-dimensional human body. There is a little difficult in adapting the time-varying distribution to the ODE. But we will try to finish it in the future.</p>
					<h1 id="future">Future*</h1>
					<p>In the future, our method may be of clinical application. As we know, an excellent medical method is hoped to solve the problem that can not be solved nowadays in the future. However, clinical issue is very long. In addition, during the issue, some patients may exit the experiment or try other methods when he/she notice the low validity of this regime. Thus we want to think a little farther.</p>
					<p>In this section, we will give the predicted survival situation of patients who receive our method. And we also try to provide the method of Dynamic Treatment Regime. All models in this section are based on Machine Learning. Because in the research of human body, the situation become so complex that we could not just use the main paramter to predict what will happen. And in many situation, fixed models can not fit the data well. So the method of Machine Learning is very significant.</p>
					<h2 id="survival-time-prediction-and-effect-prediction">Survival Time Prediction And Effect Prediction</h2>
					<h3 id="regression">Regression</h3>
					<p>In medical research, survival time and effect size are significant in judging a method successful or unsuccessful. In the experiment on mouse, we have the survival time and effect size of mice. In the clinical research, we have the survival time and effect size of patients. How does these two survival time relate with each other? There is no doubt that mouse have similarity with human, because we often use mouse for experiment. (it’s not only easy to experiment but cheap) Thus, how can we measure this similarity? And can we apply this similarity to our prediction?</p>
					<p>Actually, a lot of mice theraputic experiments fail in the clinical trials on human. Thus, a research of cross-species difference by Rachelly Normand and his team provide us a statistical model FIT to measure this similarity.</p>
					<p>We collect the mouse-to-man data on the website provided by Rachelly Normand and his team. After cleaning the data, we obtain 14757 samples. After trying a lot of time, we find that the BP neural network in regression is better than other traditional methods. So we use the BP neural network regression.</p>
					<p>In our data analysis, we find that the number of neuron can not greatly influence the fitting. We try the neural network fitting from 10 neurons to 30 neurons, and get a conclusion that the MSE is approximately 0.1 and the <span class="math inline"><em>R</em><sup>2</sup></span> is approximately 0.8, which shows that our model fit the data well.</p>
					<p>We finally decide to use 10 neurons, because it can decrease the cost of internal storage without a lost of accuracy. We also choose the Levenberg-Marquardt Algorithm for our training, and choose <span class="math inline">70%</span> data for training, <span class="math inline">15%</span> data for validation, and <span class="math inline">15%</span> data for testing. Finally, we get the fitting figure and regression figure below.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/c/c3/T--SYSU-Medicine--BPfit.png"  alt="" />
						<figcaption>
							Fitting
						</figcaption>
					</figure>
					<figure>
						<img  src="https://2019.igem.org/wiki/images/5/59/T--SYSU-Medicine--R.png" alt="" />
						<figcaption>
							Regression
						</figcaption>
					</figure>
					<p>In the experiment of M1, we got a conclusion that 29 lines showed a more than <span class="math inline">30%</span> decrease in viability 48h after exposure. In those lines, our prediction on human body is about <span class="math inline">60%</span>. That is to say, our method got a positive result based on the data.</p>
					<h3 id="whether-the-method-would-be-a-success">Whether the method would be a success?</h3>
					<p>Survival time is hard to collect because it always takes a long time. Can we just predict the clinical research a success or failure based on the survival time of mouse? Because of limited time, we haven’t recorded enough data for survival time. However, we tried to provide a probable success or failure label for different kinds of cancer.</p>
					<p>And we consider that some survival data may have deletion in the actual research, We simulate doctors’ judging rules. Doctors’ judgements are often subjective, which means, in our simulation, the threshold is often random around a fixed value. Thus, we choose the mean of the distribution to be that fixed value. And we use the random values created in the distribution <span class="math inline"><em>N</em>(<em>μ</em>, <em>σ</em><sup>2</sup>)</span> as the thresholds in every judgement. When the actual value is bigger than the threshold, we consider it successful. Otherwise, we judge it as unsuccessful. Then we use our Classification Model to make judgements according to every data from mouse. Next we could judge whether our method is successful or not when we get a new survival time difference in the control group and experiment group. The ROC is shown below. The total set AUC is approximately 0.7.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/b/b9/T--SYSU-Medicine--NPR.png" alt="" />
						<figcaption>
							ROC in Classification
						</figcaption>
					</figure>
					<h2 id="dtr">DTR*</h2>
					<p>To optimize the sequence of specific treatments for specific patients is a significant question of precision medicine. DTR (Dynamic Treatment Regime) is such a method that can explore and examine the best strategies. In this part, we will give a brief introduction of DTR model based on our method.</p>
					<p>To be brief, we choose 2 stages of treatment and 2 treatments at each stage (for example, conservative treatment(<span class="math inline"><em>A</em> =  − 1</span>) and multiple treatment of M1 and actinomycin D (A=1)). We use <span class="math inline"><em>O</em><sub><em>i</em></sub>, <em>i</em> = 1, 2</span> to describe the observation, which can be -1 or 1. <span class="math inline"><em>O</em><sub><em>i</em></sub> = 1</span> can mean the growth of the tumor, while -1 means the shrink of the tumor.</p>
					<p>The model is described as follows:<br />
						<span class="math display">$$\begin{array}{lcl} 1.\;O_i \in \{-1,1\},A_i\in\{-1,1\},for\;i=1,2;\\ 2.\;P(A_1=1)=P(A_1=-1)=0.5,P(A_2=1)=P(A_2=-1)=0.5;\\ 3.\;O_1\sim Bernoulli(0.5);\;O_2|O_1,A_1\sim Bernoilli(expit(\delta O_1+\delta A_1));\\ 4.\;Stage\;1\;outcome\;Y_1 \equiv 0;\; \\ 5.\;Stage\;2\;outcome\;Y_2=\gamma_1+\gamma_2 O_1+\gamma_3 A_1+\gamma_4 O_1 A_1+\gamma_5 A_2+\gamma_6 O_2 A_2+\gamma_7 A_1 A_2 +\varepsilon . \end{array}$$</span><br /> In the model above, <span class="math inline">$expit(x)=\frac{e^x}{1+e^x}$</span>. And <span class="math inline"><em>ε</em> ∼ <em>N</em>(0, 1)</span>. The parameters <span class="math inline"><em>γ</em><sub><em>i</em></sub>, <em>i</em> = 1 ∼ 7</span> and <span class="math inline"><em>δ</em><sub><em>i</em></sub>, <em>i</em> = 1, 2</span> can be estimated by the method of nonfitting or neural network. Thus, we can estimate the best combination of regimes as follows.(for simpleness we choose 9 parameters for our simulation, and choose the best regime based on the observation)</p>
					<table class="table table-bordered">
						<caption>
							Simulation with <span class="math inline"><em>γ</em> = (0, 0,  − 0.5, 0, 0.25, 0.5, 0.5)</span>
						</caption>
						<thead>
							<tr class="header">
								<th style="text-align: left;"><span class="math inline">(<em>O</em><sub>1</sub>, <em>O</em><sub>2</sub>)</span></th>
								<th style="text-align: left;"><span class="math inline">(<em>A</em><sub>1</sub>, <em>A</em><sub>2</sub>)</span></th>
								<th style="text-align: left;">Outcome <span class="math inline"><em>Y</em><sub>2</sub></span></th>
								<th style="text-align: left;">Remark</th>
							</tr>
						</thead>
						<tbody>
							<tr class="odd">
								<td style="text-align: left;"><span class="math inline">( − 1,  − 1)</span></td>
								<td style="text-align: left;"><span class="math inline">( − 1,  − 1)</span></td>
								<td style="text-align: left;">1.25</td>
								<td style="text-align: left;">Best</td>
							</tr>
							<tr class="even">
								<td style="text-align: left;"><span class="math inline">( − 1,  − 1)</span></td>
								<td style="text-align: left;"><span class="math inline">( − 1, 1)</span></td>
								<td style="text-align: left;">-0.25</td>
								<td style="text-align: left;"></td>
							</tr>
							<tr class="odd">
								<td style="text-align: left;"><span class="math inline">( − 1,  − 1)</span></td>
								<td style="text-align: left;"><span class="math inline">(1,  − 1)</span></td>
								<td style="text-align: left;">-0.75</td>
								<td style="text-align: left;"></td>
							</tr>
							<tr class="even">
								<td style="text-align: left;"><span class="math inline">( − 1,  − 1)</span></td>
								<td style="text-align: left;"><span class="math inline">(1, 1)</span></td>
								<td style="text-align: left;">-0.25</td>
								<td style="text-align: left;"></td>
							</tr>
							<tr class="odd">
								<td style="text-align: left;"><span class="math inline">( − 1, 1)</span></td>
								<td style="text-align: left;"><span class="math inline">( − 1,  − 1)</span></td>
								<td style="text-align: left;">0.25</td>
								<td style="text-align: left;"></td>
							</tr>
							<tr class="even">
								<td style="text-align: left;"><span class="math inline">( − 1, 1)</span></td>
								<td style="text-align: left;"><span class="math inline">( − 1, 1)</span></td>
								<td style="text-align: left;">0.75</td>
								<td style="text-align: left;">Best</td>
							</tr>
							<tr class="odd">
								<td style="text-align: left;"><span class="math inline">( − 1, 1)</span></td>
								<td style="text-align: left;"><span class="math inline">(1,  − 1)</span></td>
								<td style="text-align: left;">-1.75</td>
								<td style="text-align: left;"></td>
							</tr>
							<tr class="even">
								<td style="text-align: left;"><span class="math inline">( − 1, 1)</span></td>
								<td style="text-align: left;"><span class="math inline">(1, 1)</span></td>
								<td style="text-align: left;">0.75</td>
								<td style="text-align: left;"></td>
							</tr>
							<tr class="odd">
								<td style="text-align: left;"><span class="math inline">(1,  − 1)</span></td>
								<td style="text-align: left;"><span class="math inline">( − 1,  − 1)</span></td>
								<td style="text-align: left;">1.25</td>
								<td style="text-align: left;">Best</td>
							</tr>
							<tr class="even">
								<td style="text-align: left;"><span class="math inline">(1,  − 1)</span></td>
								<td style="text-align: left;"><span class="math inline">( − 1, 1)</span></td>
								<td style="text-align: left;">-0.25</td>
								<td style="text-align: left;"></td>
							</tr>
							<tr class="odd">
								<td style="text-align: left;"><span class="math inline">(1,  − 1)</span></td>
								<td style="text-align: left;"><span class="math inline">(1,  − 1)</span></td>
								<td style="text-align: left;">-0.75</td>
								<td style="text-align: left;"></td>
							</tr>
							<tr class="even">
								<td style="text-align: left;"><span class="math inline">(1,  − 1)</span></td>
								<td style="text-align: left;"><span class="math inline">(1, 1)</span></td>
								<td style="text-align: left;">-0.25</td>
								<td style="text-align: left;"></td>
							</tr>
							<tr class="odd">
								<td style="text-align: left;"><span class="math inline">(1, 1)</span></td>
								<td style="text-align: left;"><span class="math inline">( − 1,  − 1)</span></td>
								<td style="text-align: left;">0.25</td>
								<td style="text-align: left;"></td>
							</tr>
							<tr class="even">
								<td style="text-align: left;"><span class="math inline">(1, 1)</span></td>
								<td style="text-align: left;"><span class="math inline">( − 1, 1)</span></td>
								<td style="text-align: left;">0.75</td>
								<td style="text-align: left;">Best</td>
							</tr>
							<tr class="odd">
								<td style="text-align: left;"><span class="math inline">(1, 1)</span></td>
								<td style="text-align: left;"><span class="math inline">(1,  − 1)</span></td>
								<td style="text-align: left;">-1.75</td>
								<td style="text-align: left;"></td>
							</tr>
							<tr class="even">
								<td style="text-align: left;"><span class="math inline">(1, 1)</span></td>
								<td style="text-align: left;"><span class="math inline">(1, 1)</span></td>
								<td style="text-align: left;">0.75</td>
								<td style="text-align: left;"></td>
							</tr>
						</tbody>
					</table>
					<p>And we can choose the best regime based on the current observation. In this case, we use the Q-function:<br />
						<span class="math display">$$\left \{ \begin{array}{lcl} Q_2^{opt}(H_2,A_2;\beta_2,\psi_2)=H_{20}^T\beta_2+H_{21}^T\psi_2 A_2\\ Q_1^{opt}(H_1,A_1;\beta_1,\psi_1)=H_{10}^T\beta_1+H_{1}^T\psi_1 A_1 \end{array} \right .$$</span><br /></p>
					<p>In Q-function above, parameters are given by<br />
						<span class="math display">$$\left \{ \begin{array}{lcl} H_{20}=(1,O_1,A_1,O_1A_1),\\ H_{21}=(1,O_2,A_1),\\ H_{10}=(1,O_1)^T,\\ H_{11}=(1,O_1)^T,\\ \psi_1=\gamma_3+q_1|f_1|-q_2|f_2|+q_3|f_3|-q_4|f_4|,\\ \psi_2=\gamma_4+q_1'|f_1|-q_2'|f_2|-q_3'|f_3|+q_4'|f_4|,\\ \end{array} \right.$$</span><br /> where <span class="math inline">$q_1'=q_3'=\frac{1}{4}(expit(\delta_1+\delta_2)-expit(-\delta_1+\delta_2))$</span>,and <span class="math inline">$q_2'=q_4'=\frac{1}{4}(expit(\delta_1-\delta_2)-expit(-\delta_1-\delta_2))$</span>.</p>
					<p>Thus we could compare the effect of different regimes based on every history. The contrast is below:<br />
						<span class="math display">$$\left \{ \begin{array}{lcl} \Delta_1=Q_1^{opt}(H_1,1;\hat{\beta_1},\hat{\psi_1})-Q_1^{opt}(H_1,-1;\hat{\beta_1},\hat{\psi_1})\\ \Delta_2=Q_2^{opt}(H_2,1;\hat{\beta_2},\hat{\psi_2})-Q_2^{opt}(H_2,-1;\hat{\beta_2},\hat{\psi_2})\\ \end{array} \right.$$</span><br /></p>
					<p>And we simulate the stage 2 mean outcome slope<span class="math inline"><em></em><sup>[</sup>]</span>. We can see that while patients prefer different treatments in stage 1, there will be probably opposite best regime for patients.</p>
					<figure>
						<img src="https://2019.igem.org/wiki/images/b/b0/T--SYSU-Medicine--team-Model-Decision_Slope.png"  alt="" />
						<figcaption>
							Decision Slope
						</figcaption>
					</figure>
					<h1 id="conclusion">Conclusion</h1>
					<p>In this section, we will review our modeling detailedly. Our models have some advantages. But in the same time, the disadvantages of them are obvious. We will have a discussion about them in this section. Finally we will describe what can we do in the future.</p>
					<h2 id="advantage">Advantage</h2>
					<p>In the part of M1 Cultivation, Poisson Process is proper and it is with a low quantity of culculation, and the best times for collecting targeted virus are actually convincing because it is confirmed by the experimental results.</p>
					<p>In the part of Injection System, Improved Michaelis-Menten Equation considers the variation of concentration of nitroreductase and the best time interval for injection is convincing, confirmed by experiment as well.Integrated Injection combined the parial process and injection process together, successfully describe the relationship of microorganism and medicine; Gaussian Mixture Model realize the variation of <span class="math inline"><em>β</em></span> with the position.</p>
					<p>In the part of Targeting Ability, Effectiveness and Safety, based on the growth mechanism of M1 and the immunological effect in animals, we established an ordinary differential equation system about the number of M1, tumor cells and the time of dosing. Using ode15s and ode45s functions in MATLAB, we obtained the change curve of the number of M1, infected and uninfected tumor cells with the time of dosing, which verified the effectiveness of our system. In additional, We combined the process and results of other classical experiments to further verify the targeting ability, effectiveness and stability of our system, and used mathematical methods such as function fitting and hypothesis testing to obtain convincing results.</p>
					<p>In the final part of our model, with the help of the popular BP neural network, we predicted the effect of our system in human body, making the whole project more comprehensive and in-depth.</p>
					<h2 id="disadvantage">Disadvantage</h2>
					<p>In ODE model of part 1, the descent of concentration of uninfected tumor cells is too quick;</p>
					<p>The initial conditions of our ODE model are not correct enough. Our data is not enough, and the curve only show the trend of concentration.</p>
					<p>The time-varying distribution of <span class="math inline"><em>β</em></span> had not been added to the ODE model.</p>
					<p>Due to the difficulty of the experiment, our results can still be improved. Therefore, we have resorted to many experiments done by others to obtain our desired conclusion.</p>
					<h2 id="expectation">Expectation</h2>
					<p>It is possible to mutate M1 through directed evolution to increase its lethality and range of action while still being safe. We can improve the targeting ability, effectiveness and safety of M1 through our dosing system model and testing model. By optimizing our neural network model, we can reliably predict the effect of m1-based oncolytic virus therapy in the human body, thus accelerating the development of oncolytic virus therapy in medicine. Reference:   </p>
					<h1 id="renference">Renference</h1>
					<p>Part 1: M1 Cultivation</p>
					<p>[1]Xiangming Zhang, Zhihua Liu. Bifurcation Analysis of an Age Structured HIV Infection Model with Both Virus-to-Cell and Cell-to-Cell Transmissions. International Journal of Bifurcation and Chaos 2018 28:09</p>
					<p>[2]Ren Yonghui. Study on several tumor treatment models [D]. Shanxi normal university,2012.</p>
					<p>  </p>
					<p>Part 2: Injection System</p>
					<p>[1]Jiang Qiyuan, Xie Jinxing, Ye Jun (2010). Mathematical model (4th ed.). Beijing: China Higher Education Press, 338-346</p>
					<p>[2]Yang bowen, liu ping. Pharmacokinetics two-compartment model [J]. Journal of natural science of Harbin normal university,2016,32(01):13-15+66.</p>
					<p>[3]Yuan jin, Shi Lei, Zhao Shujin. Pharmacokinetics and Compartment Model Parameters of the Two-Compartment Model for External Vascular Administration Based on Excel Function [J]. China Pharmacy,2008(02):106-108.</p>
					<p>[4]http://2016.igem.org/Team:SYSU-MEDICINE/Modeling</p>
					<p>  </p>
					<p>Part 3: Targeting Ability, effectiveness and safety</p>
					<p>[1]Rafael Sanjuán,Valery Z Grdzelishvili. Evolution of oncolytic viruses[J]. Current Opinion in Virology,2015,13.</p>
					<p>[2]Zizi Wang,Zhiming Guo,Huaqin Peng. A mathematical model verifying potent oncolytic efficacy of M1 virus[J]. Mathematical Biosciences,2016,276.</p>
					<p>[3]Haipeng Zhang, Yuan Lin, Kai Li, Jiankai Liang, Xiao Xiao, Jing Cai, Yaqian Tan, Fan Xing, Jialuo Mai, Yuan Li, Wenli Chen, Longxiang Sheng, Jiayu Gu, Wenbo Zhu, Wei Yin, Pengxin Qiu, Xingwen Su, Bingzheng Lu, Xuyan Tian, Jinhui Liu, Wanjun Lu, Yunling Dou, Yijun Huang, Bing Hu, Zhuang Kang, Guangping Gao, Zixu Mao, Shi-Yuan Cheng, Ling Lu, Xue-Tao Bai, Shoufang Gong, Guangmei Yan, and Jun Hu. Naturally Existing Oncolytic Virus M1 Is Nonpathogenic for the Nonhuman Primates After Multiple Rounds of Repeated Intravenous Injections. Human Gene Therapy 2016 27:9, 700-711</p>
					<p>  </p>
					<p>Part 4: Future</p>
					<p>[1]Normand Rachelly,Du Wenfei,Briller Mayan,Gaujoux Renaud,Starosvetsky Elina,Ziv-Kenet Amit,Shalev-Malul Gali,Tibshirani Robert J,Shen-Orr Shai S. Found In Translation: a machine learning model for mouse-to-human inference.[J]. Nature methods,2018.</p>
					<p>[2]Bibhas Chakraborty, Erica E.M. Moodie (2013). Statistical Methods for Dynamic Treatment Regimes. New York: Springer 154-164.</p>
				</div>
			</div>

			<script>
			</script>
	</body>

</html>